CHARTWELL RETIREMENT RESIDEN (CSH-UN.CA) Stock Overview
Canada - TSX:CSH-UN - CA16141A1030
20.44 CAD
+0.13 (+0.64%)
CSH-UN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Providers & Services industry. While CSH-UN has a great profitability rating, there are quite some concerns on its financial health. CSH-UN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CSH-UN had positive earnings in the past year.
In the past year CSH-UN had a positive cash flow from operations.
Each year in the past 5 years CSH-UN has been profitable.
In the past 5 years CSH-UN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of CSH-UN (1.22%) is better than 66.67% of its industry peers.
CSH-UN has a Return On Equity of 4.30%. This is in the better half of the industry: CSH-UN outperforms 73.33% of its industry peers.
The Return On Invested Capital of CSH-UN (2.72%) is comparable to the rest of the industry.
CSH-UN had an Average Return On Invested Capital over the past 3 years of 1.89%. This is significantly below the industry average of 7.83%.
The 3 year average ROIC (1.89%) for CSH-UN is below the current ROIC(2.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.22% | ||
| ROE | 4.3% | ||
| ROIC | 2.72% |
ROA(3y)1.98%
ROA(5y)1.33%
ROE(3y)8.24%
ROE(5y)5.6%
ROIC(3y)1.89%
ROIC(5y)1.83%
1.3 Margins
The Profit Margin of CSH-UN (5.57%) is better than 80.00% of its industry peers.
CSH-UN's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 14.56%, CSH-UN belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
CSH-UN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.09%, CSH-UN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CSH-UN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.56% | ||
| PM (TTM) | 5.57% | ||
| GM | 41.09% |
OM growth 3Y27.38%
OM growth 5Y5.72%
PM growth 3Y33%
PM growth 5Y85.36%
GM growth 3Y9.65%
GM growth 5Y2.52%
2. Health
2.1 Basic Checks
CSH-UN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CSH-UN has more shares outstanding than it did 1 year ago.
CSH-UN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CSH-UN is higher compared to a year ago.
2.2 Solvency
CSH-UN has an Altman-Z score of 0.70. This is a bad value and indicates that CSH-UN is not financially healthy and even has some risk of bankruptcy.
CSH-UN has a worse Altman-Z score (0.70) than 66.67% of its industry peers.
The Debt to FCF ratio of CSH-UN is 20.20, which is on the high side as it means it would take CSH-UN, 20.20 years of fcf income to pay off all of its debts.
CSH-UN has a Debt to FCF ratio (20.20) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.93 is on the high side and indicates that CSH-UN has dependencies on debt financing.
CSH-UN's Debt to Equity ratio of 1.93 is on the low side compared to the rest of the industry. CSH-UN is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 20.2 | ||
| Altman-Z | 0.7 |
ROIC/WACC0.35
WACC7.72%
2.3 Liquidity
A Current Ratio of 0.17 indicates that CSH-UN may have some problems paying its short term obligations.
The Current ratio of CSH-UN (0.17) is worse than 66.67% of its industry peers.
CSH-UN has a Quick Ratio of 0.17. This is a bad value and indicates that CSH-UN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CSH-UN (0.17) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.17 | ||
| Quick Ratio | 0.17 |
3. Growth
3.1 Past
The earnings per share for CSH-UN have decreased strongly by -65.71% in the last year.
Measured over the past years, CSH-UN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.01% on average per year.
The Revenue has grown by 25.79% in the past year. This is a very strong growth!
The Revenue has been decreasing by -1.42% on average over the past years.
EPS 1Y (TTM)-65.71%
EPS 3Y24.01%
EPS 5YN/A
EPS Q2Q%-77.19%
Revenue 1Y (TTM)25.79%
Revenue growth 3Y-2.04%
Revenue growth 5Y-1.42%
Sales Q2Q%34.96%
3.2 Future
Based on estimates for the next years, CSH-UN will show a very strong growth in Earnings Per Share. The EPS will grow by 41.50% on average per year.
Based on estimates for the next years, CSH-UN will show a quite strong growth in Revenue. The Revenue will grow by 11.53% on average per year.
EPS Next Y50%
EPS Next 2Y44.34%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue Next Year19.56%
Revenue Next 2Y15.13%
Revenue Next 3Y11.53%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 102.20, the valuation of CSH-UN can be described as expensive.
CSH-UN's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.86. CSH-UN is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 80.95, which means the current valuation is very expensive for CSH-UN.
CSH-UN's Price/Forward Earnings ratio is in line with the industry average.
CSH-UN is valuated expensively when we compare the Price/Forward Earnings ratio to 23.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 102.2 | ||
| Fwd PE | 80.95 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CSH-UN.
CSH-UN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 43.85 | ||
| EV/EBITDA | 25.87 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CSH-UN does not grow enough to justify the current Price/Earnings ratio.
CSH-UN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CSH-UN's earnings are expected to grow with 41.50% in the coming years.
PEG (NY)2.04
PEG (5Y)N/A
EPS Next 2Y44.34%
EPS Next 3Y41.5%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.37%, CSH-UN is a good candidate for dividend investing.
CSH-UN's Dividend Yield is rather good when compared to the industry average which is at 3.27. CSH-UN pays more dividend than 100.00% of the companies in the same industry.
CSH-UN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.37% |
5.2 History
The dividend of CSH-UN decreases each year by -0.94%.
CSH-UN has been paying a dividend for at least 10 years, so it has a reliable track record.
CSH-UN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.94%
Div Incr Years1
Div Non Decr Years14
5.3 Sustainability
CSH-UN pays out 224.80% of its income as dividend. This is not a sustainable payout ratio.
DP224.8%
EPS Next 2Y44.34%
EPS Next 3Y41.5%
TSX:CSH-UN (10/2/2025, 7:00:00 PM)
20.44
+0.13 (+0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners35.65%
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap6.20B
Analysts81.54
Price Target22.04 (7.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.37% |
Yearly Dividend0.45
Dividend Growth(5Y)-0.94%
DP224.8%
Div Incr Years1
Div Non Decr Years14
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.78%
PT rev (3m)5.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)20%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)6.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 102.2 | ||
| Fwd PE | 80.95 | ||
| P/S | 6.33 | ||
| P/FCF | 43.85 | ||
| P/OCF | 22.39 | ||
| P/B | 4.89 | ||
| P/tB | 4.97 | ||
| EV/EBITDA | 25.87 |
EPS(TTM)0.2
EY0.98%
EPS(NY)0.25
Fwd EY1.24%
FCF(TTM)0.47
FCFY2.28%
OCF(TTM)0.91
OCFY4.47%
SpS3.23
BVpS4.18
TBVpS4.11
PEG (NY)2.04
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.22% | ||
| ROE | 4.3% | ||
| ROCE | 3.77% | ||
| ROIC | 2.72% | ||
| ROICexc | 2.74% | ||
| ROICexgc | 2.75% | ||
| OM | 14.56% | ||
| PM (TTM) | 5.57% | ||
| GM | 41.09% | ||
| FCFM | 14.44% |
ROA(3y)1.98%
ROA(5y)1.33%
ROE(3y)8.24%
ROE(5y)5.6%
ROIC(3y)1.89%
ROIC(5y)1.83%
ROICexc(3y)1.9%
ROICexc(5y)1.86%
ROICexgc(3y)1.92%
ROICexgc(5y)1.89%
ROCE(3y)2.62%
ROCE(5y)2.55%
ROICexcg growth 3Y21.62%
ROICexcg growth 5Y4.54%
ROICexc growth 3Y22.39%
ROICexc growth 5Y4.91%
OM growth 3Y27.38%
OM growth 5Y5.72%
PM growth 3Y33%
PM growth 5Y85.36%
GM growth 3Y9.65%
GM growth 5Y2.52%
F-Score4
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 20.2 | ||
| Debt/EBITDA | 7.02 | ||
| Cap/Depr | 65.64% | ||
| Cap/Sales | 13.84% | ||
| Interest Coverage | 0.99 | ||
| Cash Conversion | 79.34% | ||
| Profit Quality | 259.08% | ||
| Current Ratio | 0.17 | ||
| Quick Ratio | 0.17 | ||
| Altman-Z | 0.7 |
F-Score4
WACC7.72%
ROIC/WACC0.35
Cap/Depr(3y)72.18%
Cap/Depr(5y)71.77%
Cap/Sales(3y)15.27%
Cap/Sales(5y)14.56%
Profit Quality(3y)164.26%
Profit Quality(5y)249.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-65.71%
EPS 3Y24.01%
EPS 5YN/A
EPS Q2Q%-77.19%
EPS Next Y50%
EPS Next 2Y44.34%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue 1Y (TTM)25.79%
Revenue growth 3Y-2.04%
Revenue growth 5Y-1.42%
Sales Q2Q%34.96%
Revenue Next Year19.56%
Revenue Next 2Y15.13%
Revenue Next 3Y11.53%
Revenue Next 5YN/A
EBIT growth 1Y49.39%
EBIT growth 3Y24.79%
EBIT growth 5Y4.22%
EBIT Next Year224.73%
EBIT Next 3Y59.66%
EBIT Next 5YN/A
FCF growth 1Y2068.73%
FCF growth 3Y31.69%
FCF growth 5YN/A
OCF growth 1Y111.49%
OCF growth 3Y8.71%
OCF growth 5Y0.44%